Although the specific mechanism through which protein lactylation influences post-stroke epilepsy has not yet been validated, conducting research in this area may provide a new theoretical basis for using HDAC inhibitors in the clinical prevention and treatment of post-stroke epilepsy. The gene discussed is HDAC9; the disease is epilepsy.